LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Search

Smith & Nephew PLC ADR

Закрыт

30.96 -1.12

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

30.92

Макс.

31.36

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

21.217

49.052

Дивидендная доходность

2.58

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+3.19% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.58%

2.36%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-2.3B

13B

Предыдущая цена открытия

32.08

Предыдущая цена закрытия

30.96

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 июн. 2026 г., 23:36 UTC

Отчет

Correction to Oracle Reports Higher 4Q Profit Article

10 июн. 2026 г., 23:19 UTC

Популярные акции

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10 июн. 2026 г., 23:09 UTC

Главные движущие силы рынка

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10 июн. 2026 г., 23:04 UTC

Отчет

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10 июн. 2026 г., 20:44 UTC

Главные движущие силы рынка

Caterpillar Raises Quarterly Dividend 8%

10 июн. 2026 г., 23:49 UTC

Приобретения, слияния, поглощения

Elliott: Northern Star Should Take No Options Off The Table

10 июн. 2026 г., 23:48 UTC

Приобретения, слияния, поглощения

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10 июн. 2026 г., 23:48 UTC

Приобретения, слияния, поглощения

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10 июн. 2026 г., 23:47 UTC

Обсуждения рынка

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10 июн. 2026 г., 23:47 UTC

Приобретения, слияния, поглощения

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10 июн. 2026 г., 23:46 UTC

Приобретения, слияния, поглощения

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10 июн. 2026 г., 23:38 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

10 июн. 2026 г., 23:38 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

10 июн. 2026 г., 23:38 UTC

Обсуждения рынка

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10 июн. 2026 г., 23:32 UTC

Обсуждения рынка

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10 июн. 2026 г., 23:20 UTC

Обсуждения рынка

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10 июн. 2026 г., 22:05 UTC

Обсуждения рынка

Correction to Bank of Canada Stays on Hold Market Talk

10 июн. 2026 г., 21:57 UTC

Отчет

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 июн. 2026 г., 21:52 UTC

Отчет

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 июн. 2026 г., 21:35 UTC

Отчет

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 июн. 2026 г., 21:22 UTC

Отчет

Oracle Stock Slides on Increased Capital Spending -- WSJ

10 июн. 2026 г., 20:50 UTC

Обсуждения рынка
Отчет

Tech, Media & Telecom Roundup: Market Talk

10 июн. 2026 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

10 июн. 2026 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

10 июн. 2026 г., 20:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

10 июн. 2026 г., 20:39 UTC

Обсуждения рынка
Отчет

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10 июн. 2026 г., 20:34 UTC

Отчет

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 июн. 2026 г., 20:33 UTC

Отчет

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10 июн. 2026 г., 20:33 UTC

Обсуждения рынка
Отчет

Global Equities Roundup: Market Talk

10 июн. 2026 г., 20:33 UTC

Обсуждения рынка
Отчет

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

3.19% рост

Прогноз на 12 месяцев

Средняя 32.32 USD  3.19%

Максимум 35.11 USD

Минимум 30 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

4 ratings

0

Покупка

4

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat